IQVIA (NYSE:IQV) updated its FY18 earnings guidance on Friday. The company provided EPS guidance of $5.20-5.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.40. The company issued revenue guidance of $10.05-10.25 billion, compared to the consensus revenue estimate of $10.15 billion.IQVIA also updated its Q2 guidance to $1.17-1.24 EPS.
A number of equities research analysts recently issued reports on the company. SunTrust Banks reiterated a hold rating and issued a $110.00 price objective on shares of IQVIA in a research report on Monday, January 22nd. Mizuho set a $97.00 price objective on IQVIA and gave the stock a hold rating in a research report on Wednesday, January 24th. Zacks Investment Research upgraded IQVIA from a strong sell rating to a hold rating in a research report on Friday, March 23rd. Royal Bank of Canada set a $118.00 price objective on IQVIA and gave the stock a buy rating in a research report on Thursday, February 15th. Finally, JPMorgan Chase increased their price objective on IQVIA from $115.00 to $120.00 and gave the stock an overweight rating in a research report on Thursday, February 15th. Seven equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. IQVIA currently has an average rating of Buy and a consensus price target of $110.47.
IQVIA opened at $97.83 on Friday, according to Marketbeat Ratings. IQVIA has a twelve month low of $100.50 and a twelve month high of $101.78. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 1.22. The stock has a market cap of $20.53 billion, a price-to-earnings ratio of 22.44, a PEG ratio of 1.66 and a beta of 0.64.
In other news, insider James H. Erlinger III sold 10,000 shares of IQVIA stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $100.00, for a total value of $1,000,000.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Michael J. Evanisko sold 816 shares of IQVIA stock in a transaction dated Monday, March 5th. The stock was sold at an average price of $100.00, for a total value of $81,600.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,527 shares of company stock worth $1,257,834. Company insiders own 6.00% of the company’s stock.
IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.